Progression and timing of treatment of zone I retinopathy of prematurity

被引:23
作者
Soh, Yuka
Fujino, Takahiro
Hatsukawa, Yoshikazu [1 ]
机构
[1] Osaka Med Ctr, Eye Dept, Izumi Ku, Osaka 5941101, Japan
关键词
D O I
10.1016/j.ajo.2008.05.010
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE: To clarify the progression of zone I retinopathy of prematurity (ROP) and elucidate the most suitable time and method of treatment. " DESIGN: Interventional case series. METHODS: Forty-six eyes of 23 zone I ROP infants were studied at a single institution. Birth weight ranged from 448 to 954 g, and gestational age ranged from 22 to 26 weeks. Fundus examination was started at 29 or 30 weeks postmenstrual age and was performed once or more per week. The first treatment was performed using laser photocoagulation or cryotherapy when zone I ROP progressed to the following criteria. Treatment criteria A included 35 eyes of 18 cases of zone I any stage ROP with plus disease (Early Treatment for Retinopathy of Prematurity [ETROP] type 1), criteria B included five eyes of three cases of zone I stage 3 ROP with or without plus disease (ETROP type 1), criteria C included six eyes of four cases of stage I or stage 2 ROP without plus disease; the demarcation lines belonged, in large part,,vithin the zone I area. RESULTS: Hazy media such as corneal opacity, miotic pupil, tunica vasculosa lentis, and hazy vitreous persisted until approximately 32 weeks postmenstrual age. The mean period between stage I and stage 3 mild was one week, that between stage I and stage 3 moderate was 1.7 weeks, and that between stage I and stage 3 severe was 1.3 weeks. The period between stage I and the first treatment was zero to 2days, and 60.9% of all the cases were treated within 1days after stage 1. Six of 46 eyes bad unfavorable outcomes. Surgical results of our treatment were comparable or better than those of other reports. CONCLUSIONS: Immediate treatment was required when zone I ROP was diagnosed behind persistent hazy media.
引用
收藏
页码:369 / 374
页数:6
相关论文
共 27 条
[1]   CORNEAL DIAMETER IN PREMATURE-INFANTS [J].
ALUMRAN, KU ;
PANDOLFI, MF .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1992, 76 (05) :292-293
[2]   Diode laser treatment of posterior retinopathy of prematurity [J].
Axer-Siegel, R ;
Snir, M ;
Cotlear, D ;
Maayan, A ;
Frilling, R ;
Rosenbaltt, I ;
Weinberger, D ;
Kremer, I ;
Sirota, L .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (12) :1383-1386
[3]  
BLAYNEY M, 1994, J PEDIATR OPHTHALMOL, V31, P384
[4]   DIODE-LASER PHOTOCOAGULATION FOR ZONE-1 THRESHOLD RETINOPATHY OF PREMATURITY [J].
CAPONE, A ;
DIAZROHENA, R ;
STERNBERG, P ;
MANDELL, B ;
LAMBERT, M ;
LOPEZ, PF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1993, 116 (04) :444-450
[5]   DIODE-LASER PHOTOCOAGULATION FOR PRETHRESHOLD, POSTERIOR RETINOPATHY OF PREMATURITY [J].
FLEMING, TN ;
RUNGE, PE ;
CHARLES, ST .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1992, 114 (05) :589-592
[6]   Impact of the cryotherapy for retinopathy of prematurity randomized clinical trial [J].
Flynn, John T. .
ARCHIVES OF OPHTHALMOLOGY, 2007, 125 (09) :1275-1276
[7]   Outcomes after laser therapy for threshold retinopathy of prematurity [J].
Foroozan, R ;
Connolly, BP ;
Tasman, WS .
OPHTHALMOLOGY, 2001, 108 (09) :1644-1646
[8]   The international classification of retinopathy of prematurity revisited [J].
Gole, GA ;
Ells, AL ;
Katz, X ;
Holmstrom, G ;
Fielder, AR ;
Capone, A ;
Flynn, JT ;
Good, WG ;
Holmes, JM ;
McNamara, JA ;
Palmer, EA ;
Quinn, GE ;
Shapiro, MJ ;
Trese, MGJ ;
Wallace, DK .
ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (07) :991-999
[9]  
Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684
[10]   Risk analysis of prethreshold retinopathy of prematurity [J].
Hardy, RJ ;
Palmer, EA ;
Dobson, V ;
Summers, CG ;
Phelps, DL ;
Quinn, GE ;
Good, WV ;
Tung, B .
ARCHIVES OF OPHTHALMOLOGY, 2003, 121 (12) :1697-1701